Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus

Clinical trial NCT00239200 · TERMINATED

Trial details

NCT number: NCT00239200
Sponsor: University of Michigan Rogel Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus

Start date: 2005-10-01
Primary completion: 2006-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.